Mumbai: The Indian pharmaceutical and healthcare sector is expected to see moderate revenue growth, with EBITDA margins remaining flat, in the March quarter, according to a brokerage report by HDFC…
Pharma, Healthcare Firms Set for 11% Growth in Q4, Margins Under Pressure: HDFC Securities
Source: Business Medical Dialogues
Read Full Story →
